Staubach, P.; Metz, M.; Chapman-Rothe, N. et al.
Less angioedema, more quality of life and lower signs of depression in CSU during omalizumab treatmentALLERGY. Bd. 71. 2016 S. 244-245
Luther, N.; Bohn, T.; Schmitt, E. et al.
Local cyclic nucleotide repression inhibits Melanoma growthEXPERIMENTAL DERMATOLOGY. Bd. 25. 2016 S. 11-11
Kaehler, Katharina C.; Hassel, Jessica C.; Heinzerling, Lucie et al.
Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanomaJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 14. H. 7. 2016 S. 662-681
Raker, Verena K.; Ook, Kim Y.; Haub, Jessica et al.
Myeloid cell populations and fibrogenic parameters in bleomycin- and HOCl-induced fibrosisEXPERIMENTAL DERMATOLOGY. Bd. 25. H. 11. 2016 S. 887-894
Tuettenberg, Andrea; Steinbrink, Kerstin; Schuppan, Detlef
Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapyNANOMEDICINE. Bd. 11. H. 20. 2016 S. 2735-2751
Fischer, Michael R.; Kunz, Constantin; Dietze-Schwonberg, Kirsten et al.
Myeloid cells do not contribute to gender-dependent differences in disease outcome in murine cutaneous leishmaniasisCELLULAR IMMUNOLOGY. Bd. 308. 2016 S. 13-18
Grabbe, Stephan; Landfester, Katharina; Schuppan, Detlef et al.
Nanoparticles and the immune system: challenges and opportunitiesNANOMEDICINE. Bd. 11. H. 20. 2016 S. 2621-2624
Zimmer, Lisa; Goldinger, Simone M.; Hofmann, Lars et al.
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapyEUROPEAN JOURNAL OF CANCER. Bd. 60. 2016 S. 210-225
Staubach, P.; Melhorn, S.; Huenerbein, A. et al.
New developments in extemporaneous formulationsHAUTARZT. Bd. 67. H. 10. 2016 S. 833-844
Stankovic, Nevenka Dudvarski; Hoppmann, Nicola; Teodorczyk, Marcin et al.
No role of IFITM3 in brain tumor formation in vivoONCOTARGET. Bd. 7. H. 52. 2016 S. 86388-86405